A detailed history of Israel Englander (Millennium Management LLC) transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 207,257 shares of DSGN stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
207,257
Previous 610,803 66.07%
Holding current value
$1.15 Million
Previous $2.05 Million 45.5%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.19 - $5.88 $1.29 Million - $2.37 Million
-403,546 Reduced 66.07%
207,257 $1.12 Million
Q2 2024

Aug 14, 2024

BUY
$3.23 - $4.77 $408,062 - $602,617
126,335 Added 26.08%
610,803 $2.05 Million
Q1 2024

May 15, 2024

BUY
$2.27 - $4.03 $146,199 - $259,552
64,405 Added 15.33%
484,468 $1.95 Million
Q4 2023

Feb 14, 2024

BUY
$1.99 - $2.76 $278,966 - $386,907
140,184 Added 50.09%
420,063 $1.11 Million
Q2 2023

Aug 14, 2023

SELL
$4.99 - $7.64 $2.55 Million - $3.9 Million
-510,334 Reduced 64.58%
279,879 $1.76 Million
Q1 2023

May 15, 2023

BUY
$5.5 - $9.77 $1.5 Million - $2.67 Million
273,402 Added 52.9%
790,213 $4.56 Million
Q4 2022

Feb 14, 2023

BUY
$7.86 - $17.2 $2.95 Million - $6.46 Million
375,313 Added 265.24%
516,811 $5.3 Million
Q3 2022

Nov 14, 2022

BUY
$14.09 - $25.57 $1.99 Million - $3.62 Million
141,498 New
141,498 $2.37 Million

Others Institutions Holding DSGN

About Design Therapeutics, Inc.


  • Ticker DSGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,807,900
  • Market Cap $311M
  • Description
  • Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...
More about DSGN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.